Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TOPical Imiquimod Treatment of High-grade Cervical Intraepithelial Neoplasia, a Multicenter, Open-label, Non-randomized, Controlled Study (TOPIC-3 Study)

NCT02917746 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.

NCT NCT02917746
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02917746 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TOPical Imiquimod Treatment of High-grade Cervical Intraepithelial Neoplasia, a Multicenter, Open-label, Non-randomized, Controlled Study (TOPIC-3 Study)
Lead sponsor
Maastricht University Medical Center
Phase
Not applicable
Overall status
Unknown status
Start date
November 30, 2016
Completion date
December 31, 2020
Enrollment
120 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cervical intraepithelial neoplasia